The dendritic cells are the ones responsible for processing foreign proteins, molecules or particles, and presenting them to the immune system T-cells, acting as messengers and initiating the immune response.
Immune Checkpoint Blockade, or ICB therapy, has become the gold standard for treating lung cancer because of its frequently successful results. High levels of the PD-L1 protein have served as the main indicator of a favourable response to treatment up until now
New knowledge about mitochondrial DNA (mtDNA) mutations has been obtained through the use of a high-throughput single-cell, single-mitochondrial genome sequencing technique known as iMiGseq. This technology also provides a platform for evaluating mtDNA editing techniques and genetically diag
T cells, a key element of the immune system, are crucial in preventing viral infections. Extracellular vesicles are shown to be crucial in the activation of these cells in a mouse model by a team led by Prof. Thomas Brocker and Jan Kranich from the LMU Biomedical Center.
A team of researchers has uncovered how cancer evades the immune system and spreads throughout the body and is investigating ways to disable this potentially harmful trait.
Acute myeloid leukaemia (AML) is a blood cancer that causes an uncontrollable buildup of white blood cells. Due to the poor outcomes of this disease, researchers all over the world have been looking for new ways to treat AML while still allowing normal blood development to occur.
Researchers have discovered how specific proteins within roundworm chromosomes enable their offspring to produce specialised cells generations later, a startling discovery that challenges the conventional wisdom that hereditary information for cell differentiation is primarily ingrained with
Acute myeloid leukaemia (AML) is a deadly blood cancer that creates an uncontrollable buildup of white blood cells. Because of the bad outcomes of this disease, experts all over the world have been looking for novel strategies to treat AML while still allowing for normal blood development.
The health benefits of broccoli are well recognized. Research has revealed, for instance, that increasing the intake of cruciferous vegetables lowers the risk of type 2 diabetes and cancer.
According to a study, a novel medication called enoblituzumab, a monoclonal antibody, is safe in men with aggressive prostate cancer and may promote clinical action against cancer across the body.
According to new research, a biomarker signature can predict how well kidney cancer patients will respond to immunotherapy before treatment even starts. This biomarker signature is made up of the number of immune cells in and around kidney tumours, the volume of dead cancer tissue, and mutat